HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Congenital myasthenic syndrome with episodic apnea in patients homozygous for a CHAT missense mutation.

AbstractBACKGROUND:
The syndrome of congenital myasthenia with episodic apnea (CMS-EA) was previously found to be due to mutations in the choline acetyltransferase gene (CHAT).
OBJECTIVE:
To identify the mutations underlying CMS-EA in a Turkish multiplex family.
DESIGN:
Direct sequencing of the CHAT gene.
PATIENTS:
A consanguineous Turkish family with 2 siblings affected by muscular weakness and episodic respiratory distress.
RESULTS:
The sequencing of CHAT coding exons identified a previously unknown missense mutation that affected a highly conserved amino acid residue (I336T). The mutation was absent in 164 control chromosomes.
CONCLUSIONS:
The high degree of conservation in different species strongly suggests that I336T is a functionally important amino acid residue. The absence of I336T from a large control sample further supports the pathogenic role of I336T in CMS-EA. This is the second report of CHAT mutations causing presynaptic CMS.
AuthorsSimone Kraner, Iris Laufenberg, Hans M Strassburg, Joern P Sieb, Ortrud K Steinlein
JournalArchives of neurology (Arch Neurol) Vol. 60 Issue 5 Pg. 761-3 (May 2003) ISSN: 0003-9942 [Print] United States
PMID12756141 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Choline O-Acetyltransferase
Topics
  • Adult
  • Apnea (etiology, genetics)
  • Child
  • Choline O-Acetyltransferase (genetics)
  • Consanguinity
  • Family Health
  • Female
  • Homozygote
  • Humans
  • Male
  • Mutation, Missense
  • Myasthenic Syndromes, Congenital (complications, genetics)
  • Pedigree

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: